See the DrugPatentWatch profile for Vocabria
Is there a “generic Vocabria” (cabotegravir) available?
Vocabria is the brand name for cabotegravir, an oral lead-in and injectable medicine used with rilpivirine (brand: Rekambys) for HIV treatment in people whose virus is controlled. Whether a generic version is available depends on the country and whether any manufacturer has an approved generic or biosimilar equivalent. The provided information doesn’t include availability by country, so you’ll need to check local formularies or the drug regulator for your region.
What would count as a generic for Vocabria?
Because Vocabria is cabotegravir (a small-molecule medicine), a “generic Vocabria” would typically mean an approved generic cabotegravir tablet. In many markets, small-molecule “generic” products can be approved after patent and exclusivity barriers end, assuming bioequivalence requirements are met.
Does this relate to patents or exclusivity for cabotegravir?
Generic entry is usually tied to patent coverage and regulatory exclusivity for cabotegravir. If you’re trying to estimate when generic Vocabria could appear, the key dates to check are:
- Patent expiry for the relevant cabotegravir formulation/use
- Any additional exclusivity periods granted by your regulator
- Whether there are ongoing patent disputes (which can delay approval or launch)
No patent or exclusivity timeline was provided here.
Are there other cheaper alternatives if generic Vocabria isn’t available?
If a generic cabotegravir isn’t available where you live, alternatives may include:
- Different HIV regimens using other drug classes (your clinician can confirm suitability)
- Other long-acting injectable strategies (these often involve different medicines than Vocabria)
- Standard oral antiretrovirals that may be available as generics in many regions
Whether these are clinically appropriate depends on your treatment history, resistance profile, and viral suppression status.
How to check quickly for generic cabotegravir where you live
Look up “cabotegravir tablets” (generic name) in your country’s:
- National drug registry or approvals database
- Major pharmacy availability portals
- Insurance formularies
If you tell me your country (and whether you mean oral Vocabria specifically), I can tailor what to look for.
What you should ask your prescriber/pharmacist
- Is cabotegravir available as a generic in my region?
- If not, what equivalent oral regimen or manufacturer is the lowest-cost option?
- Does switching options affect eligibility for the long-acting injectable schedule (with rilpivirine)?
Sources
No sources were provided with the question, so I can’t cite availability, pricing, or regulatory status for “generic Vocabria” without additional details.